Your web browser doesn’t have the Flash Player v.9 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.
Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
Getting the first dose of GARDASIL® was an important step in helping to protect against 4 types of HPVHPVHPV stands for human papillomavirus, a common virus that affects both females and males. There are more than 100 types of HPV and most often it does not cause any symptoms and goes away on its own. Others can cause diseases of the genital area.
Get More Information
See Full Glossary and the diseases associated with these types like cervical cancerCervical cancerCervical cancer is cancer of the cervix, the lower part of the uterus that connects to the vagina. It can be a result of certain high risk types of HPV. Learn more about cervical cancer.
Get More Information
See Full Glossary and vulvar and vaginal cancers in women, and genital wartsGenital wartsGenital warts are usually flesh-coloured growths that are caused by certain types of HPV. Learn more about genital warts.
Get More Information
See Full Glossary in men and women. Now it’s time to start thinking about the other 2 doses.
As you may already know, GARDASIL® is given as 3 injections (shots) over 6 months (first dose,
2 months, 6 months). Making sure you get all 3 doses will allow you to get the full benefits. So it's important to know when you're due for your next dose.
You’re already taking time out of your busy schedule to get vaccinated with GARDASIL®.
So we’d like to help you out by reminding you when it’s time for your next dose.
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16 and 18, and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vulvar and vaginal cancers, abnormal and precancerous vulvar and vaginal cells, and genital warts. GARDASIL® is indicated in boys and men 9-26 years of age for the prevention of infection caused by HPV types 6, 11, 16 and 18, and genital warts caused by HPV types 6 and 11.
GARDASIL® helps prevent these diseases but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection over the long term has not been established. Vaccination with GARDASIL® is not recommended during pregnancy. GARDASIL® may cause side effects and allergic reactions.
Even if you get vaccinated with GARDASIL®, it is still important for women to continue having regular Pap tests.
Only a healthcare professional can decide if GARDASIL® is right for you, your son or your daughter.
Read the Patient Product Information or the Prescribing Information for more information.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Used under license.
©2010 MERCK FROSST CANADA LTD. All rights reserved.
08-11-HPV-10-CDN-84140662-AV